List of works - Anita K. Wagner

30 years of media coverage on high drug prices in the US – a never-ending story or a time for change?

scientific article published on 5 October 2015

A descriptive review of the methodologies used in household surveys on medicine utilization

scientific article

A new measure of medication affordability

scientific article

A rapidly changing global medicines environment: How adaptable are funding decision-making systems?

scientific article

Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China

scientific article published on 24 September 2013

Access to care and medicines, burden of health care expenditures, and risk protection: Results from the World Health Survey ⬇️

scientific article published on September 9, 2010

Active pharmaceutical management strategies of health insurance systems to improve cost-effective use of medicines in low- and middle-income countries: a systematic review of current evidence

scientific article published on 24 December 2010

An analysis of expenditures on primary care prescription drugs in the United States versus ten comparable countries

scientific article published on 21 July 2018

Appointment systems are essential for improving chronic disease care in resource-poor settings: learning from experiences with HIV patients in Africa

scientific article published on 12 July 2013

Article 3: 1-year impact of supervision, performance assessment, and recognition strategy (SPARS) on prescribing and dispensing quality in Ugandan health facilities

scientific article published on 01 September 2020

Availability and use of essential medicines in China: manufacturing, supply, and prescribing in Shandong and Gansu provinces

scientific article

Benzodiazepine use and hip fractures in the elderly: who is at greatest risk?

scientific article

Breast Cancer Diagnosis and Treatment After High-Deductible Insurance Enrollment

scientific article published on 28 February 2018

Cost burden of hepatitis C virus treatment in commercially insured patients

scientific article published on 01 December 2019

Costs of hospital care for hypertension in an insured population without an outpatient medicines benefit: an observational study in the Philippines

scientific article

Defining Value of Cancer Therapeutics-A Health System Perspective

scientific article published on 01 July 2018

Does access to medicines differ by gender? Evidence from 15 low and middle income countries

scientific article

Drivers of expenditure on primary care prescription drugs in 10 high-income countries with universal health coverage

scientific article published in June 2017

Effect of New York State regulatory action on benzodiazepine prescribing and hip fracture rates

scientific article

Effect of the economic recession on pharmaceutical policy and medicine sales in eight European countries

scientific article

Effects of safety warnings and risk management plan for Thiazolidinediones in Taiwan.

scientific article published on 6 August 2015

Effects of state surveillance on new post-hospitalization benzodiazepine use ⬇️

scientific article published on October 1, 2003

Erratum to: Racial disparities in all-cause mortality among younger commercially insured women with incident metastatic breast cancer

scientific article published on 30 September 2016

Essential medicines for universal health coverage

scientific article

Evaluating quality of care for patients with type 2 diabetes using electronic health record information in Mexico

scientific article

Evidence on access to medicines for chronic diseases from household surveys in five low- and middle-income countries

scientific article

Expanding access to high-cost medicines through the E2 access program in Thailand: effects on utilisation, health outcomes and cost using an interrupted time-series analysis.

scientific article published on 17 March 2016

FDA drug prescribing warnings: is the black box half empty or half full?

scientific article published on 01 June 2006

Five-year patterns of adjuvant hormonal therapy use, persistence, and adherence among insured women with early-stage breast cancer ⬇️

scientific article published on August 13, 2011

Have we improved use of medicines in developing and transitional countries and do we know how to? Two decades of evidence

scientific article published on 07 May 2013

Health care payments in the Asia Pacific: validation of five survey measures of economic burden

scientific article published on 03 July 2013

Health insurance systems in five Sub-Saharan African countries: medicine benefits and data for decision making

scientific article

Household expenditures for medicines and the role of free medicines in the Brazilian public health system

article

How Did Multiple FDA Actions Affect the Utilization and Reimbursed Costs of Thiazolidinediones in US Medicaid?

scientific article published on 11 May 2015

Impact of high-deductible insurance on adjuvant hormonal therapy use in breast cancer

scientific article published on 12 May 2018

Impact of pharmaceutical policy interventions on utilization of antipsychotic medicines in Finland and Portugal in times of economic recession: interrupted time series analyses

scientific article

Impacts of a new insurance benefit with capitated provider payment on healthcare utilization, expenditure and quality of medication prescribing in China

scientific article published on 11 November 2015

Impacts of drug reimbursement reductions on utilization and expenditures of oral antidiabetic medications in Taiwan: an interrupted time series study

scientific article published on 20 November 2013

Integrating public preferences into national reimbursement decisions: a descriptive comparison of approaches in Belgium and New Zealand

scientific article published on 25 April 2020

Measuring adherence to antiretroviral treatment in resource-poor settings: the clinical validity of key indicators

scientific article

Medicine access and utilization in a population covered by primary health care in Brazil

scientific article published on 22 August 2008

Medicines coverage and community-based health insurance in low-income countries

scientific article published on 30 October 2008

Methods for estimating confidence intervals in interrupted time series analyses of health interventions

scientific article

Need for and access to health care and medicines: are there gender inequities?

scientific article

Out-of-Pocket Cancer Care Costs and Value Frameworks: A Case Study in a Community Oncology Practice with a Financial Navigator Program

scientific article published on 19 July 2019

Out-of-pocket burden of health care spending and the adequacy of the Medicare Part D low-income subsidy

scientific article

Patient access schemes in Asia-pacific markets: current experience and future potential

scientific article

Patterns, appropriateness, and predictors of antimicrobial prescribing for adults with upper respiratory infections in urban slum communities of Bangkok.

scientific article

Payers' experiences with confidential pharmaceutical price discounts: A survey of public and statutory health systems in North America, Europe, and Australasia.

scientific article published on 16 February 2017

Policies and programs to facilitate access to targeted cancer therapies in Thailand

scientific article

Potentially inappropriate medication use by elderly persons in U.S. Health Maintenance Organizations, 2000-2001.

scientific article published in February 2005

Quality Reporting by Payers: A Mixed-Methods Study of Provider Perspectives and Practices

scientific article published on 01 July 2018

Quality use of medicines within universal health coverage: challenges and opportunities

scientific article

Racial disparities in all-cause mortality among younger commercially insured women with incident metastatic breast cancer.

scientific article published on 24 June 2016

Sales of anti-cancer medicines; China, Indonesia, Kazakhstan, Malaysia, Philippines and Thailand

scientific article published on 28 May 2020

Segmented regression analysis of interrupted time series studies in medication use research

scientific article published on 01 August 2002

Simulation-based power calculation for designing interrupted time series analyses of health policy interventions ⬇️

scientific article published on 01 November 2011

State Medicaid Reimbursement for Medications for Chronic Hepatitis C Infection from 2012 through 2015

scientific article published on 07 November 2017

The Brazilian private pharmaceutical market after the first ten years of the generics law

scientific article published on 14 August 2019

The Complex Cancer Care Coverage Environment - What is the Role of Legislation? A Case Study from Massachusetts

scientific article published on 01 September 2020

Thirty Years of Media Coverage on High Drug Prices in the United States--A Never-Ending Story or a Time for Change?

scientific article

Total and out-of-pocket expenditures among women with metastatic breast cancer in low-deductible versus high-deductible health plans

scientific article published on 01 June 2018

Uptake of new antidiabetic medications in three emerging markets: a comparison between Brazil, China and Thailand

scientific article

Urgent Need for Coordination in Adopting Standardized Antiretroviral Adherence Performance Indicators

article

Using health markets to improve access to medicines: three case studies

scientific article published on 6 May 2016

Utilization of oral antidiabetic medications in Taiwan following strategies to promote access to medicines for chronic diseases in community pharmacies

scientific article published on 25 April 2015

List of works by Anita K. Wagner

30 years of media coverage on high drug prices in the US – a never-ending story or a time for change?

A descriptive review of the methodologies used in household surveys on medicine utilization

A new measure of medication affordability

A rapidly changing global medicines environment: How adaptable are funding decision-making systems?

Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China

Access to care and medicines, burden of health care expenditures, and risk protection: Results from the World Health Survey ⬇️

Active pharmaceutical management strategies of health insurance systems to improve cost-effective use of medicines in low- and middle-income countries: a systematic review of current evidence

An analysis of expenditures on primary care prescription drugs in the United States versus ten comparable countries

Appointment systems are essential for improving chronic disease care in resource-poor settings: learning from experiences with HIV patients in Africa

Article 3: 1-year impact of supervision, performance assessment, and recognition strategy (SPARS) on prescribing and dispensing quality in Ugandan health facilities

Availability and use of essential medicines in China: manufacturing, supply, and prescribing in Shandong and Gansu provinces

Benzodiazepine use and hip fractures in the elderly: who is at greatest risk?

Breast Cancer Diagnosis and Treatment After High-Deductible Insurance Enrollment

Cost burden of hepatitis C virus treatment in commercially insured patients

Costs of hospital care for hypertension in an insured population without an outpatient medicines benefit: an observational study in the Philippines

Defining Value of Cancer Therapeutics-A Health System Perspective

Does access to medicines differ by gender? Evidence from 15 low and middle income countries

Drivers of expenditure on primary care prescription drugs in 10 high-income countries with universal health coverage

Effect of New York State regulatory action on benzodiazepine prescribing and hip fracture rates

Effect of the economic recession on pharmaceutical policy and medicine sales in eight European countries

Effects of safety warnings and risk management plan for Thiazolidinediones in Taiwan.

Effects of state surveillance on new post-hospitalization benzodiazepine use ⬇️

Erratum to: Racial disparities in all-cause mortality among younger commercially insured women with incident metastatic breast cancer

Essential medicines for universal health coverage

Evaluating quality of care for patients with type 2 diabetes using electronic health record information in Mexico

Evidence on access to medicines for chronic diseases from household surveys in five low- and middle-income countries

Expanding access to high-cost medicines through the E2 access program in Thailand: effects on utilisation, health outcomes and cost using an interrupted time-series analysis.

FDA drug prescribing warnings: is the black box half empty or half full?

Five-year patterns of adjuvant hormonal therapy use, persistence, and adherence among insured women with early-stage breast cancer ⬇️

Have we improved use of medicines in developing and transitional countries and do we know how to? Two decades of evidence

Health care payments in the Asia Pacific: validation of five survey measures of economic burden

Health insurance systems in five Sub-Saharan African countries: medicine benefits and data for decision making

Household expenditures for medicines and the role of free medicines in the Brazilian public health system

How Did Multiple FDA Actions Affect the Utilization and Reimbursed Costs of Thiazolidinediones in US Medicaid?

Impact of high-deductible insurance on adjuvant hormonal therapy use in breast cancer

Impact of pharmaceutical policy interventions on utilization of antipsychotic medicines in Finland and Portugal in times of economic recession: interrupted time series analyses

Impacts of a new insurance benefit with capitated provider payment on healthcare utilization, expenditure and quality of medication prescribing in China

Impacts of drug reimbursement reductions on utilization and expenditures of oral antidiabetic medications in Taiwan: an interrupted time series study

Integrating public preferences into national reimbursement decisions: a descriptive comparison of approaches in Belgium and New Zealand

Measuring adherence to antiretroviral treatment in resource-poor settings: the clinical validity of key indicators

Medicine access and utilization in a population covered by primary health care in Brazil

Medicines coverage and community-based health insurance in low-income countries

Methods for estimating confidence intervals in interrupted time series analyses of health interventions

Need for and access to health care and medicines: are there gender inequities?

Out-of-Pocket Cancer Care Costs and Value Frameworks: A Case Study in a Community Oncology Practice with a Financial Navigator Program

Out-of-pocket burden of health care spending and the adequacy of the Medicare Part D low-income subsidy

Patient access schemes in Asia-pacific markets: current experience and future potential

Patterns, appropriateness, and predictors of antimicrobial prescribing for adults with upper respiratory infections in urban slum communities of Bangkok.

Payers' experiences with confidential pharmaceutical price discounts: A survey of public and statutory health systems in North America, Europe, and Australasia.

Policies and programs to facilitate access to targeted cancer therapies in Thailand

Potentially inappropriate medication use by elderly persons in U.S. Health Maintenance Organizations, 2000-2001.

Quality Reporting by Payers: A Mixed-Methods Study of Provider Perspectives and Practices

Quality use of medicines within universal health coverage: challenges and opportunities

Racial disparities in all-cause mortality among younger commercially insured women with incident metastatic breast cancer.

Sales of anti-cancer medicines; China, Indonesia, Kazakhstan, Malaysia, Philippines and Thailand

Segmented regression analysis of interrupted time series studies in medication use research

Simulation-based power calculation for designing interrupted time series analyses of health policy interventions ⬇️

State Medicaid Reimbursement for Medications for Chronic Hepatitis C Infection from 2012 through 2015

The Brazilian private pharmaceutical market after the first ten years of the generics law

The Complex Cancer Care Coverage Environment - What is the Role of Legislation? A Case Study from Massachusetts

Thirty Years of Media Coverage on High Drug Prices in the United States--A Never-Ending Story or a Time for Change?

Total and out-of-pocket expenditures among women with metastatic breast cancer in low-deductible versus high-deductible health plans

Uptake of new antidiabetic medications in three emerging markets: a comparison between Brazil, China and Thailand

Urgent Need for Coordination in Adopting Standardized Antiretroviral Adherence Performance Indicators

Using health markets to improve access to medicines: three case studies

Utilization of oral antidiabetic medications in Taiwan following strategies to promote access to medicines for chronic diseases in community pharmacies